Jan 23 (Reuters) - NMT Medical Inc (NMTI.O) said it will close a trial testing its technology in treating migraine that may be caused by a heart defect, due to difficulties in enrolling subjects.
In a statement, the company said it will now focus on testing the technology in patients who may develop stroke as a result of a heart malfunction. (Reporting by Varsha Tickoo in Bangalore)
WASHINGTON (Reuters) - The economy grew at a much slower pace than previously thought in the third quarter, restrained by weak business investment and a slightly more aggressive liquidation of inventories, data showed on Tuesday.
Democrats are on the verge of passing landmark legislation by Christmas, with only one more hurdle remaining. Full Article | Video
Borrowing the dollar cheaply to fund purchases of higher-yielding assets was a no-brainer in 2009, but will it be a safe bet in 2010? Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
